Arnab Chowdry

Arnab joined 23andMe in 2009 and is the architect of 23andMe’s platform for processing genetic data. Among other duties, Arnab oversees the design and analytic validity of our genotyping technology.

Over the years he has been instrumental in several successful upgrades of our testing infrastructure, as well as ensuring that the data from new genotyping chips work seamlessly with 23andMe’s product and research platform.

Before joining 23andMe, Arnab earned his Ph.D. in Biophysics from the University of California at Berkeley, where he studied computational protein design, and developed protein inhibitors for breast cancer metastasis with Dr. Tracy Handel. Before that received a SmileTrain grant for his work with Dr. Simeon Boyadjiev at the Johns Hopkins Children's Hospital to determine the disease-causing loci for rare genetic conditions such as oculodentodigital dysplasia.

Originally from Rochester, New York, Arnab has been interested in genetics since childhood.